Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Hospitalization for Infection in Patients with Primary Autoimmune Hemolytic Anemia Treated with Rituximab. a Prospective, Nationwide Cohort Study in France

Yoann Zadro, Margaux Lafaurie, Maryse Lapeyre-Mestre, Marc Michel, Guillaume Moulis

Blood (2023) 142 (Supplement 1): 1082.

https://doi.org/10.1182/blood-2023-173444

Published: 2023

Journal Articles

Drug-Induced Autoimmune Hemolytic Anemia: Detection of New Signals in the World Pharmacovigilance Database and Risk Assessment in a Nationwide Cohort Study in France

Julien Maquet, Margaux Lafaurie, Marc Michel, Maryse Lapeyre-Mestre, Guillaume Moulis

Blood (2022) 140 (Supplement 1): 8176–8177.

https://doi.org/10.1182/blood-2022-157730

Published: 2022

Journal Articles

Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease

Ondine Walter, Pierre Cougoul, Julien Maquet, Pablo Bartolucci, Maryse Lapeyre-Mestre, Margaux Lafaurie, Guillaume Moulis

Blood (2022) 139 (26): 3771–3777.

https://doi.org/10.1182/blood.2021014473

Published: 2022

Includes: Supplemental data

Journal Articles

Increased Risk of Ischemic Stroke Amongst Patients with Primary Autoimmune Hemolytic Anemia in Denmark and France

Dennis Lund Hansen, Julien Maquet, Margaux Lafaurie, Sigbjørn Berentsen, Henrik Frederiksen, Guillaume Moulis, David Gaist

Blood (2021) 138 (Supplement 1): 849.

https://doi.org/10.1182/blood-2021-151615

Published: 2021

Journal Articles

Risk of Hospitalization for Vaso-Occlusive Episode in Patients with Sickle Cell Disease after out-Patient Exposure to Systemic Corticosteroids

Ondine Walter, Pierre Cougoul, Julien Maquet, Pablo Bartolucci, Maryse Lapeyre-Mestre, Margaux Lafaurie, Guillaume Moulis

Blood (2021) 138 (Supplement 1): 2048.

https://doi.org/10.1182/blood-2021-151307

Published: 2021

Journal Articles

Autoimmune Hemolytic Anemia: A Disease of the Elderly and the Very Elderly with Increased Mortality and Increased Rates of Hospitalization for Thrombosis and Infection

Julien Maquet, Margaux Lafaurie, PharmD, PhDstudent, Agnès Sommet, MD PhD, Maryse Lapeyre-Mestre, MD PhD, Guillaume Moulis

Blood (2020) 136 (Supplement 1): 41.

https://doi.org/10.1182/blood-2020-137545

Published: 2020

Journal Articles

Eltrombopag for Immune Thrombocytopenia in Adult Patients in the Real-World in France. Final Results of the Elextra Study

Guillaume Moulis, Manuela Rueter, MSc, Margaux Lafaurie, PharmD, PhDstudent, Maryse Lapeyre-Mestre, MD PhD

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-139967

Published: 2020

Journal Articles

Eltrombopag for Immune Thrombocytopenia Adult Patients in the Real-Life Practice in France. Interim Results of the Elextra Study

Guillaume Moulis, MD PhD, Manuela Rueter, MSc, Margaux Lafaurie, PharmD, Maryse Lapeyre-Mestre, MD PhD, Carmen investigators Group

Blood (2019) 134 (Supplement_1): 2372.

https://doi.org/10.1182/blood-2019-126000

Published: 2019

Journal Articles

Risk of Immune Thrombocytopenia Induced By Influenza Vaccine. a Nationwide Population-Based Study in France

Margaux Lafaurie, PharmD, Bérangère Baricault, Maryse Lapeyre-Mestre, MD PhD, Laurent Sailler, MD PhD, Agnès Sommet, MD PhD, Guillaume Moulis, MD PhD

Blood (2019) 134 (Supplement_1): 1086.

https://doi.org/10.1182/blood-2019-124720

Published: 2019

Journal Articles

No Increased Risk of Cataract in Immune Thrombocytopenia Adult Patients Treated with Eltrombopag. a French Nationwide Nested Case-Control Study

Margaux Lafaurie, PharmD, Bérangère Baricault, Vincent Soler, MD PhD, Myriam Cassagne, MD PhD, Laurent Sailler, MD PhD, Maryse Lapeyre-Mestre, MD PhD, Agnès Sommet, MD PhD, Guillaume Moulis, MD PhD

Blood (2019) 134 (Supplement_1): 2363.

https://doi.org/10.1182/blood-2019-124729

Published: 2019

Journal Articles

Risk Factors of Thrombosis in Adults with Primary Immune Thrombocytopenia. a French Nationwide Cohort Study

Guillaume Moulis, MD PhD, Bérangère Baricault, Charlotta Ekstrand, Margaux Lafaurie, PharmD, Christian Fynbo Christiansen, Marie Linder, Shahram Bahmanyar, Mette Nørgaard, MD PhD, Laurent Sailler, MD PhD, Maryse Lapeyre-Mestre, MD PhD

Blood (2018) 132 (Supplement 1): 3745.

https://doi.org/10.1182/blood-2018-99-112506

Published: 2018

Journal Articles

Risk of Vaccine-Induced Immune Thrombocytopenia in Children . Nationwide Case Cross-over and Self-Controlled Case Series Studies in France

Margaux Lafaurie, PharmD, Bérangère Baricault, Maryse Lapeyre-Mestre, MD PhD, Laurent Sailler, MD PhD, Agnès Sommet, MD PhD, Guillaume Moulis, MD PhD

Blood (2018) 132 (Supplement 1): 738.

https://doi.org/10.1182/blood-2018-99-110522

Published: 2018

Journal Articles

Prevalence of Cardiovascular Risk Factors and Incidence of Venous and Arterial Thrombosis in Non-Splenectomized Immune Thrombocytopenia Adult Patients in Sweden and France. Results from Two Nationwide Studies

Charlotta Ekstrand, Bérangère Baricault, Marie Linder, Margaux Lafaurie, Laurent Sailler, Maryse Lapeyre-Mestre, Helle Kieler, Shahram Bahmanyar, Guillaume Moulis, MD

Blood (2017) 130 (Supplement 1): 1040.

https://doi.org/10.1182/blood.V130.Suppl_1.1040.1040

Published: 2017

NARROW

Hospitalization for Infection in Patients with Primary Autoimmune Hemolytic Anemia Treated with Rituximab. a Prospective, Nationwide Cohort Study in France

Drug-Induced Autoimmune Hemolytic Anemia: Detection of New Signals in the World Pharmacovigilance Database and Risk Assessment in a Nationwide Cohort Study in France

Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease

Increased Risk of Ischemic Stroke Amongst Patients with Primary Autoimmune Hemolytic Anemia in Denmark and France

Risk of Hospitalization for Vaso-Occlusive Episode in Patients with Sickle Cell Disease after out-Patient Exposure to Systemic Corticosteroids

Autoimmune Hemolytic Anemia: A Disease of the Elderly and the Very Elderly with Increased Mortality and Increased Rates of Hospitalization for Thrombosis and Infection

Eltrombopag for Immune Thrombocytopenia in Adult Patients in the Real-World in France. Final Results of the Elextra Study

Eltrombopag for Immune Thrombocytopenia Adult Patients in the Real-Life Practice in France. Interim Results of the Elextra Study

Risk of Immune Thrombocytopenia Induced By Influenza Vaccine. a Nationwide Population-Based Study in France

No Increased Risk of Cataract in Immune Thrombocytopenia Adult Patients Treated with Eltrombopag. a French Nationwide Nested Case-Control Study

Risk Factors of Thrombosis in Adults with Primary Immune Thrombocytopenia. a French Nationwide Cohort Study

Risk of Vaccine-Induced Immune Thrombocytopenia in Children . Nationwide Case Cross-over and Self-Controlled Case Series Studies in France

Prevalence of Cardiovascular Risk Factors and Incidence of Venous and Arterial Thrombosis in Non-Splenectomized Immune Thrombocytopenia Adult Patients in Sweden and France. Results from Two Nationwide Studies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only